Rheumnow Podcast

Apr 11 2025 936 ep. 25 mins 385
Rheumnow Podcast artwork

Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com

  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


EMR Messaging Woes (4.11.2025)

Apr 11 2025 18 mins  
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on RheumNow.com

An Epidural Letdown (4.4.2025)

Apr 04 2025 21 mins  
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. **Correction: a Tweet from 3/18 podcast, had incorrect information. Late Breaking abstract from 2025 Amer. Acad. Dermatology (AAD) on the Phase 3 ICONIC-LEAD study showed J&J's oral IL-23 inhibitor (icotrokinra) was superior to PLACEBO (not deucravacitinib as reported) in skin clearance (65%

Biomarkers in RA

Apr 01 2025 11 mins  
Rheumatologist Dr. Walter Maksymowych discusses the role of biomarkers in RA care, with a focus on 14-3-3eta as a modifiable marker for diagnosis and monitoring disease progression.

Cancer Survival with TNF Inhibitors (3.28.2025)

Mar 28 2025 22 mins  
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com

ERA, APPs, & Alpha GAL (3.21.2025)

Mar 21 2025 33 mins  
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Listen in for 2 new case questions - Ask Cush Anything.

World Changers (3.14.2025)

Mar 14 2025 26 mins  
Dr Jack Cush and his podcast friends are out to change the world. Here is his weekly review of the news and journal reports from the past week on RheumNow.com

Autoimmune Myositis The Role of the Laboratory in Diagnosis and Phenotyping Sponsored by LabCorp

Mar 12 2025 60 mins  
Hear from rheumatologist Stanley J. Naides MD, FACP, FACR, as he details the clinical features of autoimmune myositis, the associated phenotypes and autoantibodies, plus the methodologies and testing options to support a myositis diagnosis.

EXXELERATE: New Thoughts on High RF Titer Sponsored by: UCB

Mar 10 2025 17 mins  
Two leading rheumatologists share insights into why RF levels are important to consider when identifying treatment options for patients with RA.

Hydroxychloro-King (3.7.2025)

Mar 07 2025 15 mins  
Dr. Jack Cush reviews the news, journal reports and regulatory actions from the past week on RheumNow.com

Treatment goals for RA- Is it time to transition to MOAs? Sponsored by AbbVie Medical Affairs

Mar 01 2025 16 mins